UBS has given Nutrien a 'Neutral' rating and set a target price of $51.
The Swiss bank's analyst, Joshua Spector, stated that Nutrien's third-quarter performance was in line with expectations but slightly below consensus estimates. The report noted that Nutrien's operating results were somewhat weak, although the company is making progress in managing costs and investments.
This assessment comes as Nutrien continues to face challenges in the agricultural sector.